|
RFWD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.06430000004865E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.07700000004674E-06 |
| Normal-vs-Stage2 |
1.473890E-02 |
| Normal-vs-Stage3 |
3.56719999983213E-07 |
| Normal-vs-Stage4 |
1.077900E-03 |
| Stage1-vs-Stage2 |
3.812000E-01 |
| Stage1-vs-Stage3 |
1.153350E-01 |
| Stage1-vs-Stage4 |
6.835400E-01 |
| Stage2-vs-Stage3 |
8.181900E-02 |
| Stage2-vs-Stage4 |
6.872400E-01 |
| Stage3-vs-Stage4 |
1.415160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.46340000012546E-07 |
| Normal-vs-AfricanAmerican |
2.010600E-04 |
| Normal-vs-Asian |
1.332240E-01 |
| Caucasian-vs-AfricanAmerican |
9.759800E-01 |
| Caucasian-vs-Asian |
7.801600E-01 |
| AfricanAmerican-vs-Asian |
7.654000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.83750000057626E-08 |
| Normal-vs-Female |
3.420500E-04 |
| Male-vs-Female |
3.685600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.156600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.34600000001317E-06 |
| Normal-vs-Age(61-80Yrs) |
8.37560000022108E-07 |
| Normal-vs-Age(81-100Yrs) |
6.483200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.246600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.058200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.096600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.300400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.651800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.918000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.128480E-02 |
| Normal-vs-Grade 2 |
3.201300E-04 |
| Normal-vs-Grade 3 |
9.71540004002236E-09 |
| Normal-vs-Grade 4 |
3.179200E-03 |
| Grade 1-vs-Grade 2 |
4.523800E-01 |
| Grade 1-vs-Grade 3 |
6.781200E-01 |
| Grade 1-vs-Grade 4 |
6.585400E-01 |
| Grade 2-vs-Grade 3 |
1.058170E-02 |
| Grade 2-vs-Grade 4 |
8.029400E-01 |
| Grade 3-vs-Grade 4 |
2.000600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.32230000000767E-05 |
| Normal-vs-ccB subtype |
3.21489999999258E-06 |
| ccA subtype-vs-ccB subtype |
3.225000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.94539999999588E-05 |
| Normal-vs-N1 |
7.679600E-01 |
| N0-vs-N1 |
1.274760E-01 |
|
|
